Literature DB >> 17403375

Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver.

Shawn C Burgess1, TianTeng He, Zheng Yan, Jill Lindner, A Dean Sherry, Craig R Malloy, Jeffrey D Browning, Mark A Magnuson.   

Abstract

When dietary carbohydrate is unavailable, glucose required to support metabolism in vital tissues is generated via gluconeogenesis in the liver. Expression of phosphoenolpyruvate carboxykinase (PEPCK), commonly considered the control point for liver gluconeogenesis, is normally regulated by circulating hormones to match systemic glucose demand. However, this regulation fails in diabetes. Because other molecular and metabolic factors can also influence gluconeogenesis, the explicit role of PEPCK protein content in the control of gluconeogenesis was unclear. In this study, metabolic control of liver gluconeogenesis was quantified in groups of mice with varying PEPCK protein content. Surprisingly, livers with a 90% reduction in PEPCK content showed only a approximately 40% reduction in gluconeogenic flux, indicating a lower than expected capacity for PEPCK protein content to control gluconeogenesis. However, PEPCK flux correlated tightly with TCA cycle activity, suggesting that under some conditions in mice, PEPCK expression must coordinate with hepatic energy metabolism to control gluconeogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17403375      PMCID: PMC2680089          DOI: 10.1016/j.cmet.2007.03.004

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  38 in total

Review 1.  Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis.

Authors:  S J Pilkis; D K Granner
Journal:  Annu Rev Physiol       Date:  1992       Impact factor: 19.318

Review 2.  Metabolic control through the PGC-1 family of transcription coactivators.

Authors:  Jiandie Lin; Christoph Handschin; Bruce M Spiegelman
Journal:  Cell Metab       Date:  2005-06       Impact factor: 27.287

3.  Rate-limiting steps in metabolic pathways.

Authors:  R Rognstad
Journal:  J Biol Chem       Date:  1979-03-25       Impact factor: 5.157

4.  Quantifying gluconeogenesis during fasting.

Authors:  V Chandramouli; K Ekberg; W C Schumann; S C Kalhan; J Wahren; B R Landau
Journal:  Am J Physiol       Date:  1997-12

5.  Regulation of glucose-6-phosphatase gene expression by protein kinase Balpha and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and -independent effects of insulin on promoter activity.

Authors:  D Schmoll; K S Walker; D R Alessi; R Grempler; A Burchell; S Guo; R Walther; T G Unterman
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

6.  Diminished hepatic gluconeogenesis via defects in tricarboxylic acid cycle flux in peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha)-deficient mice.

Authors:  Shawn C Burgess; Teresa C Leone; Adam R Wende; Michelle A Croce; Zhouji Chen; A Dean Sherry; Craig R Malloy; Brian N Finck
Journal:  J Biol Chem       Date:  2006-05-02       Impact factor: 5.157

7.  Quantitative contributions of gluconeogenesis to glucose production during fasting in type 2 diabetes mellitus.

Authors:  A Wajngot; V Chandramouli; W C Schumann; K Ekberg; P K Jones; S Efendic; B R Landau
Journal:  Metabolism       Date:  2001-01       Impact factor: 8.694

8.  Regulation of net hepatic glycogenolysis and gluconeogenesis during exercise: impact of type 1 diabetes.

Authors:  Kitt Falk Petersen; Thomas B Price; Raynald Bergeron
Journal:  J Clin Endocrinol Metab       Date:  2004-09       Impact factor: 5.958

9.  Inhibition of gluconeogenesis in isolated rat hepatocytes after chronic treatment with phenobarbital.

Authors:  D Argaud; S Halimi; F Catelloni; X M Leverve
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

10.  Use of 2H2O for estimating rates of gluconeogenesis. Application to the fasted state.

Authors:  B R Landau; J Wahren; V Chandramouli; W C Schumann; K Ekberg; S C Kalhan
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

View more
  137 in total

1.  The effect of short-term fasting on liver and skeletal muscle lipid, glucose, and energy metabolism in healthy women and men.

Authors:  Jeffrey D Browning; Jeannie Baxter; Santhosh Satapati; Shawn C Burgess
Journal:  J Lipid Res       Date:  2011-12-03       Impact factor: 5.922

2.  Alpha-lipoic acid attenuates insulin resistance and improves glucose metabolism in high fat diet-fed mice.

Authors:  Yi Yang; Wang Li; Yang Liu; Yan Li; Ling Gao; Jia-jun Zhao
Journal:  Acta Pharmacol Sin       Date:  2014-08-25       Impact factor: 6.150

Review 3.  The mitochondrial isoform of phosphoenolpyruvate carboxykinase (PEPCK-M) and glucose homeostasis: has it been overlooked?

Authors:  Romana Stark; Richard G Kibbey
Journal:  Biochim Biophys Acta       Date:  2013-10-28

4.  Molecular characterization of insulin-mediated suppression of hepatic glucose production in vivo.

Authors:  Christopher J Ramnanan; Dale S Edgerton; Noelia Rivera; Jose Irimia-Dominguez; Ben Farmer; Doss W Neal; Margaret Lautz; E Patrick Donahue; Catalina M Meyer; Peter J Roach; Alan D Cherrington
Journal:  Diabetes       Date:  2010-02-25       Impact factor: 9.461

5.  Pyruvate-Carboxylase-Mediated Anaplerosis Promotes Antioxidant Capacity by Sustaining TCA Cycle and Redox Metabolism in Liver.

Authors:  David A Cappel; Stanisław Deja; João A G Duarte; Blanka Kucejova; Melissa Iñigo; Justin A Fletcher; Xiaorong Fu; Eric D Berglund; Tiemin Liu; Joel K Elmquist; Suntrea Hammer; Prashant Mishra; Jeffrey D Browning; Shawn C Burgess
Journal:  Cell Metab       Date:  2019-04-18       Impact factor: 27.287

6.  Fibroblast growth factor 21 increases hepatic oxidative capacity but not physical activity or energy expenditure in hepatic peroxisome proliferator-activated receptor γ coactivator-1α-deficient mice.

Authors:  Justin A Fletcher; Melissa A Linden; Ryan D Sheldon; Grace M Meers; E Matthew Morris; Anthony Butterfield; James W Perfield; R Scott Rector; John P Thyfault
Journal:  Exp Physiol       Date:  2018-01-16       Impact factor: 2.969

Review 7.  Regulation of pyruvate metabolism in metabolic-related diseases.

Authors:  Nam Ho Jeoung; Chris R Harris; Robert A Harris
Journal:  Rev Endocr Metab Disord       Date:  2014-03       Impact factor: 6.514

8.  Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice.

Authors:  Stephan Wueest; Reto A Rapold; Desiree M Schumann; Julia M Rytka; Anita Schildknecht; Ori Nov; Alexander V Chervonsky; Assaf Rudich; Eugen J Schoenle; Marc Y Donath; Daniel Konrad
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

9.  Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver.

Authors:  Santhosh Satapati; Blanka Kucejova; Joao A G Duarte; Justin A Fletcher; Lacy Reynolds; Nishanth E Sunny; Tianteng He; L Arya Nair; Kenneth A Livingston; Kenneth Livingston; Xiaorong Fu; Matthew E Merritt; A Dean Sherry; Craig R Malloy; John M Shelton; Jennifer Lambert; Elizabeth J Parks; Ian Corbin; Mark A Magnuson; Jeffrey D Browning; Shawn C Burgess
Journal:  J Clin Invest       Date:  2015-11-16       Impact factor: 14.808

10.  Effects of insulin on the metabolic control of hepatic gluconeogenesis in vivo.

Authors:  Dale S Edgerton; Christopher J Ramnanan; Carrie A Grueter; Kathryn M S Johnson; Margaret Lautz; Doss W Neal; Phillip E Williams; Alan D Cherrington
Journal:  Diabetes       Date:  2009-09-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.